Ewing’s sarcoma (EWS) is a bone and soft tissue carcinoma that produces an Ewing’s sarcoma–Friend leukemia integration 1 (EWS-FLI1) fusion protein, which is a transcription factor that may be a drug target for the disease [82,83]. This evidence concerns the gene EWSR1 and Ewing sarcoma.